Genus-optimized strategy for the identification of chlamydial type III secretion substrates

被引:20
|
作者
Hovis, Kelley M. [1 ]
Mojica, Sergio [1 ]
McDermott, Jason E. [2 ]
Pedersen, Laura [1 ]
Simhi, Chana [1 ]
Rank, Roger G. [3 ]
Myers, Garry S. A. [4 ]
Ravel, Jacques [4 ]
Hsia, Ru-ching [5 ]
Bavoil, Patrik M. [1 ]
机构
[1] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA
[2] Pacific NW Natl Lab, Richland, WA 99352 USA
[3] Arkansas Childrens Hosp, Res Inst, Little Rock, AR 72202 USA
[4] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA
[5] Univ Maryland, Sch Dent, Core Imaging Facil, Baltimore, MD 21201 USA
来源
PATHOGENS AND DISEASE | 2013年 / 69卷 / 03期
基金
美国国家卫生研究院;
关键词
Chlamydia; type III secretion; effector; YERSINIA-PSEUDOTUBERCULOSIS; TRANSLOCATED PROTEIN; PNEUMONIAE; INFECTION; CYCLE; LOCALIZATION; CHAPERONES; EXPRESSION; PREDICTION; DEATH;
D O I
10.1111/2049-632X.12070
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Among chlamydial virulence factors are the type III secretion (T3S) system and its effectors. T3S effectors target host proteins to benefit the infecting chlamydiae. The assortment of effectors, each with a unique function, varies between species. This variation likely contributes to differences in host specificity and disease severity. A dozen effectors of Chlamydia trachomatis have been identified; however, estimates suggest that more exist. A T3S prediction algorithm, SVM-based Identification and Evaluation of Virulence Effectors (SIEVE), along with a Yersinia surrogate secretion system helped to identify a new T3S substrate, CT082, which rather than functioning as an effector associates with the chlamydial envelope after secretion. SIEVE was modified to improve/expand effector predictions to include all sequenced genomes. Additional adjustments were made to the existing surrogate system whereby the N terminus of putative effectors was fused to a known effector lacking its own N terminus and was tested for secretion. Expansion of effector predictions by cSIEVE and modification of the surrogate system have also assisted in identifying a new T3S substrate from C.psittaci. The expanded predictions along with modifications to improve the surrogate secretion system have enhanced our ability to identify novel species-specific effectors, which upon characterization should provide insight into the unique pathogenic properties of each species. The manuscript describes the application of new algorithms for computational discovery of type III secretion substrates in Chlamydiae, a group of pathogenic bacteria with limited experimental tools available for virulence gene discovery.
引用
收藏
页码:213 / 222
页数:10
相关论文
共 50 条
  • [21] Identification and characterization of a type III secretion-associated chaperone in the type III secretion system 1 of Vibrio parahaemolyticus
    Akeda, Yukihiro
    Okayama, Kanna
    Kimura, Tomomi
    Dryselius, Rikard
    Kodama, Toshio
    Oishi, Kazunori
    Iida, Tetsuya
    Honda, Takeshi
    FEMS MICROBIOLOGY LETTERS, 2009, 296 (01) : 18 - 25
  • [22] Identification and characterization of a type III secretion system in Chlamydophila psittaci
    Beeckman, Delphine Sylvie Anne
    Geens, Tom
    Timmermans, Jean-Pierre
    Van Oostveldt, Patrick
    Vanrompay, Daisy C. G.
    VETERINARY RESEARCH, 2008, 39 (03)
  • [23] Identification of a type III secretion system in uropathogenic Escherichia coli
    Miyazaki, J
    Ba-Thein, W
    Kumao, T
    Akaza, H
    Hayashi, H
    FEMS MICROBIOLOGY LETTERS, 2002, 212 (02) : 221 - 228
  • [24] An optimized growth medium for increased recombinant protein secretion titer via the type III secretion system
    Burdette, Lisa Ann
    Wong, Han Teng
    Tullman-Ercek, Danielle
    MICROBIAL CELL FACTORIES, 2021, 20 (01)
  • [25] An optimized growth medium for increased recombinant protein secretion titer via the type III secretion system
    Lisa Ann Burdette
    Han Teng Wong
    Danielle Tullman-Ercek
    Microbial Cell Factories, 20
  • [26] Impassable YscP substrates and their impact on the Yersinia enterocolitica type III secretion pathway
    Riordan, Kelly E.
    Sorg, Joseph A.
    Berube, Bryan J.
    Schneewind, Olaf
    JOURNAL OF BACTERIOLOGY, 2008, 190 (18) : 6204 - 6216
  • [27] Benzylidene Acylhydrazides Inhibit Chlamydial Growth in a Type III Secretion- and Iron Chelation-Independent Manner
    Bao, Xiaofeng
    Gylfe, Asa
    Sturdevant, Gail L.
    Gong, Zheng
    Xu, Shuang
    Caldwell, Harlan D.
    Elofsson, Mikael
    Fan, Huizhou
    JOURNAL OF BACTERIOLOGY, 2014, 196 (16) : 2989 - 3001
  • [28] How do Ralstonia solanacearum type III chaperones modulate the secretion of type III substrates and play essential roles in virulence?
    Lonjon, F.
    Turner, M.
    Lohou, D.
    Henry, C.
    Rengel, D.
    Ebrahimi, N. S. Razavi
    Sabbagh, C. R. R.
    Le Ru, A.
    Peeters, N.
    Roux, F.
    Genin, S.
    Vailleau, F.
    MOLECULAR PLANT-MICROBE INTERACTIONS, 2019, 32 (10) : 133 - 133
  • [29] Identification of Vibrio cholerae Type III Secretion System Effector Proteins
    Alam, Ashfaqul
    Miller, Kelly A.
    Chaand, Mudit
    Butler, J. Scott
    Dziejman, Michelle
    INFECTION AND IMMUNITY, 2011, 79 (04) : 1728 - 1740
  • [30] Analysis of putative Chlamydia trachomatis chaperones Scc2 and Scc3 and their use in the identification of type III secretion substrates
    Fields, KA
    Fischer, ER
    Mead, DJ
    Hackstadt, T
    JOURNAL OF BACTERIOLOGY, 2005, 187 (18) : 6466 - 6478